Bismuth‐containing quadruple therapy versus concomitant quadruple therapy as first‐line treatment for <i>Helicobacter Pylori</i> infection in an area of high resistance to clarithromycin: A prospective, cross‐sectional, comparative, open trial

Abstract

The use of CQT and BQT as first-line treatment against H. pylori is similarly effective and safe strategy in an area of high clarithromycin resistance.